Harmony Biosciences Holdings, Inc. (HRMY) vs Pharvaris N.V. (PHVS)

A side-by-side comparison of Harmony Biosciences Holdings, Inc. and Pharvaris N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Harmony Biosciences Holdings, Inc. logo
HRMY
Harmony Biosciences Holdings, Inc.
$2.30B
$39.78HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Pharvaris N.V. logo
PHVS
Pharvaris N.V.
$2.15B
$30.71HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — HRMY vs PHVS

growth of $100 · dividends reinvested · last 6y
HRMY +2.7% (+0.4%/yr)PHVS +5.1% (+0.8%/yr)PHVS compounded faster over this window
050100150Start $10020222023202420252026$103$105
HRMY PHVS

HRMY vs PHVS: by the numbers

  • •HRMY is the larger company ($2.30B vs $2.15B market cap).
  • •HRMY is profitable (18.88% net margin) while PHVS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricHRMYPHVS
P/E ratio12.91N/A
Forward P/E10.09N/A
P/S ratio2.40N/A
P/B ratio2.306.25
EV / EBITDA7.45N/A
FCF yield15.41%N/A

Profitability

MetricHRMYPHVS
Gross margin75.42%0.00%
Operating margin24.03%0.00%
Net margin18.88%0.00%
ROE18.14%-57.96%
ROIC14.96%-61.74%

Growth (annualized)

MetricHRMYPHVS
Revenue CAGR (5Y)32.47%N/A
FCF CAGR (5Y)48.43%N/A
Total return CAGR (5Y)0.91%11.45%

Frequently asked

Is HRMY or PHVS more profitable?
HRMY runs the higher net margin — HRMY at 18.88% versus PHVS at 0.00%.
How have HRMY and PHVS total returns compared?
Over the past 5 years, HRMY delivered 0.91% and PHVS delivered 11.45% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HRMY analysisFull PHVS analysisInteractive comparison tool

Dig into the metrics

Harmony Biosciences P/E ratioHarmony Biosciences ROEPharvaris ROEHarmony Biosciences operating marginPharvaris operating marginHarmony Biosciences revenue growthPharvaris revenue growthHarmony Biosciences free cash flowPharvaris free cash flow

Harmony Biosciences & Pharvaris appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.